Порівняння методів
Переглядайте обрані методи поруч; рядки з відмінностями підсвічено.
| Прагматичний аналіз виживаності× | Модель пропорційних ризиків Кокса× | |
|---|---|---|
| Галузь | Епідеміологія | Епідеміологія |
| Родина | Process / pipeline | Process / pipeline |
| Рік появи≠ | Conceptual framework: 1967; widespread application: 1990s–2000s | 1972 |
| Автор методу≠ | Schwartz & Lellouch (explanatory vs. pragmatic distinction, 1967); extended in survival analysis literature from the 1970s onward | Sir David Roxbee Cox |
| Тип≠ | Observational / experimental hybrid — time-to-event analysis in real-world or pragmatic-trial settings | Semi-parametric regression model |
| Основоположне джерело≠ | Ford, I., & Norrie, J. (2016). Pragmatic Trials. New England Journal of Medicine, 375(5), 454–463. DOI ↗ | Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society: Series B (Methodological), 34(2), 187–202. DOI ↗ |
| Інші назви | real-world survival analysis, pragmatic time-to-event analysis, effectiveness survival analysis, PSA | Cox regression, Cox PH model, proportional hazards model, CPH |
| Пов'язані | 5 | 5 |
| Підсумок≠ | Pragmatic survival analysis applies time-to-event statistical methods within pragmatic or real-world settings, estimating how long patients survive, remain event-free, or retain treatment benefit under conditions of routine clinical practice. Unlike explanatory survival analyses conducted under tightly controlled trial conditions, the pragmatic variant embraces the heterogeneity, treatment switching, non-adherence, and competing events that characterise real-world patient populations, prioritising external validity over internal precision. | The Cox proportional hazards model is a semi-parametric regression method that estimates the effect of one or more covariates on the hazard — the instantaneous rate of an event such as death, relapse, or failure — while making no assumption about the shape of the baseline hazard function. Introduced by David Cox in 1972, it is the dominant tool for multivariable survival analysis in clinical and epidemiological research. |
| ScholarGateНабір даних ↗ |
|
|